Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis"

Affiliations

¹ European Society for Clinical Microbiology and Infectious Diseases, ESCMID, Basel, Switzerland; Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Denmark; International Society for Infectious Diseases, ISID, Boston, USA. Electronic address: eskild.petersen@gmail.com.
² Department of Medicine and Infectious Disease, Georgetown University Medstar Hospital, Washington DC, USA; Infectious Disease Society of America, IDSA, Arlington, USA.
³ National Institute for Communicable Diseases of the National Health Laboratory Service and University of Pretoria, South Africa.
⁴ New York State Department of Health, The Arbovirus Laboratory, Wadsworth Center, Slingerlands, New York, USA; Department of Biomedical Sciences, State University of New York at Albany School of Public Health, Albany, New York, USA; International Society for Infectious Diseases, ISID, Boston, USA.
⁵ Directorate General for Disease Surveillance and Control, Ministry of Health, Oman.
⁶ JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
⁷ Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
⁸ Clinical Research Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Global Health, University of Amsterdam, Faculty of Medicine, Amsterdam, Noord-Holland, The Netherlands.
⁹ Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Americas, Pereira, Colombia.
¹⁰ Centre d'Entomologie Médicale et Vétérinaire, CEMV-Université Alassane Ouattara, Bouaké, Cote d'Ivoire.
¹¹ Department of Community Medicine, Ahmadu Bello University Zaria, Nigeria.
¹² International Society for Infectious Diseases, ISID, Boston, USA; Department of Medicine and Infectious Diseases, Translational Research Program, National University of Singapore, Singapore.
¹³ International Society for Infectious Diseases, ISID, Boston, USA; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, W12 0NN, UK; Department of Infectious Diseases, Imperial College London, London, SW7 2AZ, UK.
¹⁴ International Society of Travel Medicine, ISTM, Atlanta, USA; Harvard Medical School, Boston, USA; Travel Medicine Center, Mount Auburn Hospital, Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, USA.

PMID: 33639296
PMCID: PMC7903148
DOI: 10.1016/j.ijid.2021.02.076

Comment

Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis"

Eskild Petersen et al. Int J Infect Dis. 2021 Apr.

. 2021 Apr:105:409-410.

doi: 10.1016/j.ijid.2021.02.076. Epub 2021 Feb 24.

Authors

Affiliations

¹ European Society for Clinical Microbiology and Infectious Diseases, ESCMID, Basel, Switzerland; Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Denmark; International Society for Infectious Diseases, ISID, Boston, USA. Electronic address: eskild.petersen@gmail.com.
² Department of Medicine and Infectious Disease, Georgetown University Medstar Hospital, Washington DC, USA; Infectious Disease Society of America, IDSA, Arlington, USA.
³ National Institute for Communicable Diseases of the National Health Laboratory Service and University of Pretoria, South Africa.
⁴ New York State Department of Health, The Arbovirus Laboratory, Wadsworth Center, Slingerlands, New York, USA; Department of Biomedical Sciences, State University of New York at Albany School of Public Health, Albany, New York, USA; International Society for Infectious Diseases, ISID, Boston, USA.
⁵ Directorate General for Disease Surveillance and Control, Ministry of Health, Oman.
⁶ JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
⁷ Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
⁸ Clinical Research Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Global Health, University of Amsterdam, Faculty of Medicine, Amsterdam, Noord-Holland, The Netherlands.
⁹ Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Americas, Pereira, Colombia.
¹⁰ Centre d'Entomologie Médicale et Vétérinaire, CEMV-Université Alassane Ouattara, Bouaké, Cote d'Ivoire.
¹¹ Department of Community Medicine, Ahmadu Bello University Zaria, Nigeria.
¹² International Society for Infectious Diseases, ISID, Boston, USA; Department of Medicine and Infectious Diseases, Translational Research Program, National University of Singapore, Singapore.
¹³ International Society for Infectious Diseases, ISID, Boston, USA; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, W12 0NN, UK; Department of Infectious Diseases, Imperial College London, London, SW7 2AZ, UK.
¹⁴ International Society of Travel Medicine, ISTM, Atlanta, USA; Harvard Medical School, Boston, USA; Travel Medicine Center, Mount Auburn Hospital, Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, USA.

PMID: 33639296
PMCID: PMC7903148
DOI: 10.1016/j.ijid.2021.02.076

No abstract available

PubMed Disclaimer

Comment in

Global COVID-19 vaccine equity should precede requiring travelers proof of vaccination.
Franco-Paredes C, Suarez JA, Henao-Martínez AF. Franco-Paredes C, et al. Int J Infect Dis. 2021 Apr;105:243-244. doi: 10.1016/j.ijid.2021.02.061. Epub 2021 Feb 26. Int J Infect Dis. 2021. PMID: 33640569 Free PMC article. No abstract available.

Comment on

COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis.
Petersen E, Lucey D, Blumberg L, Kramer LD, Al-Abri S, Lee SS, Pinto TCA, Obiero CW, Rodriguez-Morales AJ, Yapi R, Abubakar A, Tambyah PA, Holmes A, Chen LH. Petersen E, et al. Int J Infect Dis. 2021 Mar;104:175-177. doi: 10.1016/j.ijid.2021.01.039. Epub 2021 Jan 20. Int J Infect Dis. 2021. PMID: 33482380 Free PMC article. No abstract available.

References

1. COVAX . 2020. Working for global equitable access to COVID-19 vaccines.https://www.who.int/initiatives/act-accelerator/covax
1. Kim David S., Rowland-Jones Sarah, Gea-Mallorquí Ester. Will SARS-CoV-2 infection elicit long lasting protective or sterilising immunity? Implications for vaccine strategies. Front Immunol. 2020;11:571481. doi: 10.3389/fimmu.2020.571481. - DOI - PMC - PubMed
1. Le Bert N., Tan A.T., Kunasegaran K., Tham C.Y.L., Hafezi M., Chia A. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584:457–462. doi: 10.1038/s41586-020-2550-z. - DOI - PubMed
1. Nguyen-Contant P., Embong A.K., Kanagaiah P., Chaves F.A., Yang H., Branche A.R. S protein-reactive IgG and memory B cell production after human SARS-CoV-2 infection includes broad reactivity to the S2 subunit. mBio. 2020;11(September (5)):e01991–20. doi: 10.1128/mBio.01991-20. - DOI - PMC - PubMed
1. Petersen E., Lucey D., Blumberg L., Kramer L.D., Al-Abri S., Lee S.S. COVID-19 vaccines under the International Health Regulations — we must use the WHO International Certificate of Vaccination or Prophylaxis. Int J Infect Dis. 2021;104(January):175–177. doi: 10.1016/j.ijid.2021.01.039. Online ahead of print. - DOI - PMC - PubMed

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis"

Affiliations

Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis"

Authors

Affiliations

Comment in

Comment on

References

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources